Clinical Trials Directory

Trials / Unknown

UnknownNCT01825759

Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function

The Impact of Compound Danshen Dropping Pill for Coronary Heart Disease With Hypertension Patient Heart and Artery Structure and Function

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Accepted

Summary

The Impact of Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension

Detailed description

Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension.We can accorand the pwv ,IMT and MDA to assess the impact of heart and artery structure and function.

Conditions

Interventions

TypeNameDescription
DRUGdanshen dripping pill

Timeline

Start date
2013-01-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-04-08
Last updated
2013-04-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01825759. Inclusion in this directory is not an endorsement.

Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function (NCT01825759) · Clinical Trials Directory